Table 1. Changes in T-TAS^® Parameters of In Vitro Experiments in the Rivaroxaban and Apixaban.

	Rivaroxaban (n = 16)		Apixaban (n = 4)
	Control	Spiked	Control	Spiked
AR-T10 (min)	7.9 ± 2.2	16.1 ± 4.5*	6.7 ± 0.2	14.0 ± 1.3*
AR-T80 (min)	12.4 ± 2.4	22.6 ± 3.2*	11.4 ± 1.1	22.6 ± 2.2*
PL-T10 (min)	2.3 ± 0.7	2.9 ± 0.7	2.2 ± 1.1	2.8 ± 0.7
PL-T60 (min)	6.0 ± 1.7	6.6 ± 1.3	6.2 ± 2.6	6.2 ± 1.5

Continuous variables are expressed as mean ± SD. *P < 0.05 vs. control.